CoLabs
Morgan Hill, US · 3 known investors
CoLabs Medical is developing The Ventor, an emergency airway and ventilation system intended to improve airway management and ventilation during cardiac arrest. The product is positioned as a complete solution for emergency medicine and is currently an investigational device under development.
Founders & leadership
CN
Clay NolaninFounder, CEO
RC
Robert CrockettNamed on SEC filing
CB
Chris BakerNamed on SEC filing
BM
Bob MellenNamed on SEC filing
MD
Michael D. LauferNamed on SEC filing
Investors · 3
Reported raises · per SEC filings
Form D private placements$1.8M disclosed across 1 round · 2018
▶$1.8MraisedJun 2019 · 27 investors · Other Health CareRule 506(b)
▶$1.8MraisedJun 2019 · 27 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robert CrockettExecutive Officer, Director
- Chris BakerDirector
- Bob MellenDirector
- Michael D. LauferDirector
- Clay NolanExecutive Officer, Director
- Offering amount
- $2.1M
- Amount sold
- $1.8M
- Minimum investment
- $1
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does CoLabs do?
- CoLabs Medical is developing The Ventor, an emergency airway and ventilation system intended to improve airway management and ventilation during cardiac arrest. The product is positioned as a complete solution for emergency medicine and is currently an investigational device under development.
- Who founded CoLabs?
- CoLabs was founded by Clay Nolan.
- Who are CoLabs's investors?
- CoLabs's investors include Aphelion Capital, Healthtech Capital, Seraph Group.
- How much funding has CoLabs raised?
- CoLabs has disclosed $1.8M raised across 1 round.
- Where is CoLabs headquartered?
- CoLabs is headquartered in Morgan Hill, US.